DK0695301T3 - Indolderivater som 5-HT1-lignende agonister til anvendelse ved migræne - Google Patents
Indolderivater som 5-HT1-lignende agonister til anvendelse ved migræneInfo
- Publication number
- DK0695301T3 DK0695301T3 DK94913573.5T DK94913573T DK0695301T3 DK 0695301 T3 DK0695301 T3 DK 0695301T3 DK 94913573 T DK94913573 T DK 94913573T DK 0695301 T3 DK0695301 T3 DK 0695301T3
- Authority
- DK
- Denmark
- Prior art keywords
- pct
- migraine
- agonists
- indole derivatives
- date oct
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
- C07D209/16—Tryptamines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Child & Adolescent Psychology (AREA)
- Otolaryngology (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939308360A GB9308360D0 (en) | 1993-04-22 | 1993-04-22 | Indoles |
| GB939324433A GB9324433D0 (en) | 1993-11-27 | 1993-11-27 | Indoles |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0695301T3 true DK0695301T3 (da) | 1996-12-09 |
Family
ID=26302791
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK94913573.5T DK0695301T3 (da) | 1993-04-22 | 1994-04-11 | Indolderivater som 5-HT1-lignende agonister til anvendelse ved migræne |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US5607960A (no) |
| EP (1) | EP0695301B1 (no) |
| JP (1) | JP2802169B2 (no) |
| KR (1) | KR960701865A (no) |
| CN (1) | CN1121348A (no) |
| AT (1) | ATE144773T1 (no) |
| AU (1) | AU6567094A (no) |
| BR (1) | BR9406481A (no) |
| CA (1) | CA2157397C (no) |
| CZ (1) | CZ274595A3 (no) |
| DE (1) | DE69400824T2 (no) |
| DK (1) | DK0695301T3 (no) |
| ES (1) | ES2094653T3 (no) |
| FI (1) | FI954944A (no) |
| GR (1) | GR3021804T3 (no) |
| HU (1) | HUT73807A (no) |
| IL (1) | IL109337A0 (no) |
| NO (1) | NO954168L (no) |
| NZ (1) | NZ265269A (no) |
| PL (1) | PL311204A1 (no) |
| WO (1) | WO1994024127A1 (no) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5607951A (en) * | 1990-10-15 | 1997-03-04 | Pfizer Inc | Indole derivatives |
| US5578612A (en) * | 1990-10-15 | 1996-11-26 | Pfizer Inc. | Indole derivatives |
| US5559129A (en) * | 1990-10-15 | 1996-09-24 | Pfizer Inc | Indole derivatives |
| US5559246A (en) * | 1990-10-15 | 1996-09-24 | Pfizer Inc. | Indole derivatives |
| US5545644A (en) * | 1990-10-15 | 1996-08-13 | Pfizer Inc. | Indole derivatives |
| EP0716649B1 (en) * | 1993-08-31 | 1998-09-09 | Pfizer Inc. | 5-arylindole derivatives |
| GB9417310D0 (en) | 1994-08-27 | 1994-10-19 | Pfizer Ltd | Therapeutic agents |
| GB9420503D0 (en) * | 1994-10-11 | 1994-11-23 | Pfizer Ltd | Therapeutic agents |
| GB9420529D0 (en) | 1994-10-12 | 1994-11-30 | Pfizer Ltd | Indoles |
| AU702322B2 (en) * | 1995-03-20 | 1999-02-18 | Eli Lilly And Company | 5-substituted-3-(1,2,3,6-tetrahydropyridin-4-yl)- and 3-(piperidin-4-yl)-1h-indoles: new 5-ht1f agonists |
| US5872145A (en) * | 1996-08-16 | 1999-02-16 | Pozen, Inc. | Formulation of 5-HT agonist and NSAID for treatment of migraine |
| US6586458B1 (en) | 1996-08-16 | 2003-07-01 | Pozen Inc. | Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs |
| US8022095B2 (en) | 1996-08-16 | 2011-09-20 | Pozen, Inc. | Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs |
| AU4074897A (en) * | 1996-09-18 | 1998-04-14 | Eli Lilly And Company | A method for the prevention of migraine |
| WO1998023587A1 (en) * | 1996-11-26 | 1998-06-04 | Allelix Biopharmaceuticals Inc. | 5-cyclo indole compounds as 5-ht1d receptor ligands |
| US5856510A (en) * | 1996-12-16 | 1999-01-05 | Allelix Biopharmaceuticals Inc. | 5-alkenyl and 5-alkynyl indole compounds |
| US5998462A (en) * | 1996-12-16 | 1999-12-07 | Allelix Biopharmaceuticals Inc. | 5-alkyl indole compounds |
| GB9705035D0 (en) * | 1997-03-11 | 1997-04-30 | Pharmacia & Upjohn Spa | Indolyl-pyrrolydenemethylpyrrole derivatives and process for their preparation |
| EP0875513A1 (en) * | 1997-04-14 | 1998-11-04 | Eli Lilly And Company | Substituted heteroaromatic 5-HT 1F agonists |
| CA2299286A1 (en) * | 1997-08-09 | 1999-02-18 | Laramie Mary Gaster | Bicyclic compounds as ligands for 5-ht1 receptors |
| US6310066B1 (en) | 1998-04-29 | 2001-10-30 | American Home Products Corp. | Antipsychotic indolyl derivatives |
| US6204274B1 (en) | 1998-04-29 | 2001-03-20 | American Home Products Corporation | Indolyl derivatives as serotonergic agents |
| US6066637A (en) * | 1998-06-19 | 2000-05-23 | American Home Products Corporation | Indolyl derivatives as serotonergic agents |
| AU4961499A (en) * | 1998-06-26 | 2000-01-17 | Eli Lilly And Company | 5-HT1f agonists |
| US5994352A (en) * | 1998-11-13 | 1999-11-30 | Pfizer Inc. | 5-arylindole derivatives |
| MXPA02012927A (es) * | 2000-07-21 | 2003-05-15 | Lundbeck & Co As H | Derivados de indol utiles para el tratamiento de padecimientos del sistema nervioso central. |
| US6489512B1 (en) * | 2002-06-21 | 2002-12-03 | Rhodia Chirex Inc. | Method for making aryl hydrazines and substituted indoles |
| MXPA05006076A (es) * | 2002-12-10 | 2005-08-16 | Merck Patent Gmbh | Derivados de indol y su uso como ligandos 5-ht. |
| CA2508290C (en) | 2002-12-20 | 2017-02-28 | Ciba Specialty Chemicals Holding Inc. | Synthesis of amines and intermediates for the synthesis thereof |
| MXPA05006954A (es) * | 2002-12-26 | 2005-09-22 | Pozen Inc | Formas de dosificacion de capas multiples que contienen nsaids y triptanos. |
| AU2004247076A1 (en) * | 2003-06-06 | 2004-12-23 | Glaxo Group Limited | Composition comprising triptans and NSAIDs |
| US20050245540A1 (en) * | 2003-12-09 | 2005-11-03 | Fujisawa Pharmaceutical Co., Ltd. | New methods |
| WO2005066157A1 (en) * | 2004-01-02 | 2005-07-21 | Suven Life Sciences | 3-(pyrolidin-3-l) indoles as 5-ht6 receptor modulators |
| GB0807772D0 (en) * | 2008-04-29 | 2008-06-04 | Lectus Therapeutics Ltd | Calcium ion modulators and uses thereof |
| FR2953720B1 (fr) * | 2009-12-11 | 2012-05-11 | Oreal | Utilisation de derives de benzyloxy-ethylamines comme conservateur, |
| CN104557957B (zh) * | 2013-10-09 | 2017-04-19 | 华东师范大学 | 螺‑氧化吲哚环氧乙烷衍生物的合成方法 |
| KR20220137085A (ko) * | 2020-02-04 | 2022-10-11 | 마인드셋 파마 인크. | Cns 장애의 치료를 위한 세로토닌성 사이키델릭 작용제로서의 3-피롤리딘-인돌 유도체 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8530507D0 (en) * | 1985-12-11 | 1986-01-22 | Glaxo Group Plc | Chemical compounds |
| GB8719167D0 (en) * | 1987-08-13 | 1987-09-23 | Glaxo Group Ltd | Chemical compounds |
| HU225055B1 (en) * | 1990-10-15 | 2006-05-29 | Pfizer | Indole derivatives, their intermediates, process for production them and pharmaceutical compositions containing the compounds |
-
1994
- 1994-04-11 AT AT94913573T patent/ATE144773T1/de not_active IP Right Cessation
- 1994-04-11 JP JP6522726A patent/JP2802169B2/ja not_active Expired - Fee Related
- 1994-04-11 WO PCT/EP1994/001121 patent/WO1994024127A1/en not_active Application Discontinuation
- 1994-04-11 ES ES94913573T patent/ES2094653T3/es not_active Expired - Lifetime
- 1994-04-11 US US08/532,573 patent/US5607960A/en not_active Expired - Fee Related
- 1994-04-11 CA CA002157397A patent/CA2157397C/en not_active Expired - Fee Related
- 1994-04-11 DK DK94913573.5T patent/DK0695301T3/da active
- 1994-04-11 PL PL94311204A patent/PL311204A1/xx unknown
- 1994-04-11 NZ NZ265269A patent/NZ265269A/en unknown
- 1994-04-11 DE DE69400824T patent/DE69400824T2/de not_active Expired - Fee Related
- 1994-04-11 CN CN94191850A patent/CN1121348A/zh active Pending
- 1994-04-11 AU AU65670/94A patent/AU6567094A/en not_active Abandoned
- 1994-04-11 KR KR1019950704623A patent/KR960701865A/ko not_active Application Discontinuation
- 1994-04-11 BR BR9406481A patent/BR9406481A/pt not_active Application Discontinuation
- 1994-04-11 EP EP94913573A patent/EP0695301B1/en not_active Expired - Lifetime
- 1994-04-11 CZ CZ952745A patent/CZ274595A3/cs unknown
- 1994-04-11 HU HU9501920A patent/HUT73807A/hu unknown
- 1994-04-18 IL IL10933794A patent/IL109337A0/xx unknown
-
1995
- 1995-10-17 FI FI954944A patent/FI954944A/fi not_active Application Discontinuation
- 1995-10-19 NO NO954168A patent/NO954168L/no unknown
-
1996
- 1996-11-28 GR GR960403195T patent/GR3021804T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NZ265269A (en) | 1996-09-25 |
| PL311204A1 (en) | 1996-02-05 |
| IL109337A0 (en) | 1994-07-31 |
| GR3021804T3 (en) | 1997-02-28 |
| JP2802169B2 (ja) | 1998-09-24 |
| ES2094653T3 (es) | 1997-01-16 |
| CN1121348A (zh) | 1996-04-24 |
| DE69400824T2 (de) | 1997-03-13 |
| NO954168D0 (no) | 1995-10-19 |
| NO954168L (no) | 1995-10-19 |
| WO1994024127A1 (en) | 1994-10-27 |
| HUT73807A (en) | 1996-09-30 |
| CA2157397C (en) | 1999-07-06 |
| EP0695301A1 (en) | 1996-02-07 |
| US5607960A (en) | 1997-03-04 |
| HU9501920D0 (en) | 1995-09-28 |
| DE69400824D1 (de) | 1996-12-05 |
| FI954944A0 (fi) | 1995-10-17 |
| FI954944A (fi) | 1995-10-17 |
| EP0695301B1 (en) | 1996-10-30 |
| CA2157397A1 (en) | 1994-10-27 |
| JPH08507083A (ja) | 1996-07-30 |
| AU6567094A (en) | 1994-11-08 |
| CZ274595A3 (en) | 1996-03-13 |
| KR960701865A (ko) | 1996-03-28 |
| BR9406481A (pt) | 1996-01-09 |
| ATE144773T1 (de) | 1996-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0695301T3 (da) | Indolderivater som 5-HT1-lignende agonister til anvendelse ved migræne | |
| DK0544819T3 (da) | Indolderivater, som inhiberer leukotrienbiosyntese | |
| FI960399A0 (fi) | Perhydroisoindolijohdannaisia P-aineen antagonisteina | |
| ES2138364T3 (es) | Procedimiento para el almacenamiento reversible de hidrogeno. | |
| ES2121193T3 (es) | Derivados de bencimidazoles. | |
| DK0771197T3 (da) | Anvendelse af heterocykliske forbindelser som dopamin-D3-ligander | |
| NO983002L (no) | Vitronectin-reseptor-antagonister | |
| DK0772604T3 (da) | Trialzolforbindelser og deres anvendelse som dopamin-D3-ligander | |
| DK0778771T3 (da) | Topiske ketoconazolemulsioner | |
| ES2185660T3 (es) | Nuevo uso de dexmedetomidina. | |
| NO980178L (no) | Cyklo-oksygenase-inhibitor og amidin-derivatsalter, fremgangsmåte for fremstilling derav, anvendelse derav som legemidler, og farmasöytiske blandinger inneholdende slike derivater | |
| IL152097A0 (en) | Use of pyrazole derivatives for treating infertility | |
| DE69819742D1 (de) | Indolderivate als 5-ht1b und 5-ht1d agonisten | |
| DK0764022T3 (da) | Agonister og antagonister af de nikotinerge acetylcholinreceptorer hos insekter som endoparasiticider | |
| NO20002408L (no) | 5-HT1F antagonister | |
| ATE197453T1 (de) | Imidazol-, triazol- und tetrazolderivate | |
| DK0943030T3 (da) | Fremgangsmåde til reduktion af svovl- og kypefarvestoffer | |
| FI953002A0 (fi) | Menetelmä kroonisen eturauhastulehduksen hoitamiseksi 17beta-N-monosubstituoiduilla karbamoyyli-4-atsa-5alfa-androst-1-en-3-oneilla | |
| DK1163248T3 (da) | 1,5-anhydro-D-fructose substitueret med en hydrofob gruppe til brug som en antioxidant og/eller emulgator | |
| DK0948457T3 (da) | Fremgangsmåde til regenerering af anthraquinon-derivater under proces til syntese af hydrogenperoxid | |
| YU29496A (sh) | So pirolidinil metil indola | |
| DK0923549T3 (da) | Methansulfonatsalt af et arylpiperazin afledt af tryptamin og solvater deraf til farmaceutisk anvendelse | |
| ES2181791T3 (es) | Derivados de indol para el tratamiento de la migraña. |